Response to Crizotinib Observed in Lung Adenocarcinoma with MET Copy Number Gain but without a High-Level MET/CEP7 Ratio, MET Overexpression, or Exon 14 Splicing Mutations
Zhang, Yan, Wang, WeiYa, Wang, Yan, Xu, Yong, Tian, Ye, Huang, MeiJuan, Lu, YouLanguage:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2015.12.102
Date:
December, 2015
File:
PDF, 1.36 MB
english, 2015